RDR1-mediated broad antitumor response: a novel strategy manipulating miRNAs as a powerful weapon

References

[1] Otto T, Sicinski P. Cell cycle proteins as promising targets in cancer therapy. Nat Rev Cancer 2017;17:93–115.

[2] Hydbring P, Wang Y, Fassl A, et al. Cell-cycle-targeting MicroRNAs as therapeutic tools against refractory cancers. Cancer Cell 2017;31:576–90.

[3] Bartel DP. Metazoan MicroRNAs. Cell 2018;173:20–51.

[4] Lin S, Gregory RI. MicroRNA biogenesis pathways in cancer. Nat Rev Cancer 2015;15:321–33.

[5] Cao M, Du P, Wang X, et al. Virus infection triggers widespread silencing of host genes by a distinct class of endogenous siRNAs in Arabidopsis. Proc Natl Acad Sci USA 2014;111:14613–18.

[6] Qi Y, Ding L, Zhang S, et al. A plant immune protein enables broad antitumor response by rescuing microRNA deficiency. Cell 2022;185:1888–1904.

[7] Curaba J, Chen X. Biochemical activities of Arabidopsis RNA-dependent RNA polymerase 6. J Biol Chem 2008;283:3059–66.

[8] Galka-Marciniak P, Urbanek-Trzeciak MO, Nawrocka PM, et al. A pan-cancer atlas of somatic mutations in miRNA biogenesis genes. Nucleic Acids Res 2021;49:601–20.

[9] Aalto AP, Poranen MM, Grimes JM, et al. In Vitro activities of the multifunctional RNA silencing polymerase QDE-1 of Neurospora crassa*[S]. J Biol Chem 2010;285:29367–74.

[10] Heo I, Ha M, Lim J, et al. Mono-uridylation of pre-microRNA as a key step in the biogenesis of group II let-7 microRNAs. Cell 2012;151:521–32.

RIGHTS & PERMISSIONS

2022 The Author(s) 2022. Published by Oxford University Press on behalf of Higher Education Press.